Seth A. Tasker - 11 Jan 2022 Form 4 Insider Report for INFINITY PHARMACEUTICALS, INC.

Signature
/s/Seth A. Tasker
Issuer symbol
N/A
Transactions as of
11 Jan 2022
Net transactions value
$0
Form type
4
Filing time
12 Jan 2022, 16:00:48 UTC

Quoteable Key Fact

"Seth A. Tasker filed Form 4 for INFINITY PHARMACEUTICALS, INC. on 12 Jan 2022."

Quick Takeaways

  • This page summarizes Seth A. Tasker's Form 4 filing for INFINITY PHARMACEUTICALS, INC..
  • 1 reported transaction and 1 derivative row are listed below.
  • Filing timestamp: 12 Jan 2022, 16:00.

What Changed

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Source Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INFI Stock Option (right to buy) Award $0 +225,000 $0.000000 225,000 11 Jan 2022 Common Stock 225,000 $1.53 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/48th of the shares on January 31, 2022 and vests as to 1/48th of the shares at the end of each calendar month thereafter.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .